Discern Health

News

W2O has bought US health economics and outcomes research company Discern Health, marking its sixth acquisition in less than a year.

News

With $81.3 million raised, Vogenx is the latest in a staggering summer of biotech IPOs. But the queue past this point looks thin.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.